Healthcare -
Biotechnology - NASDAQ - CH
$ 44.04
0.273 %
$ 3.78 B
Market Cap
-10.15
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
CRISPR Therapeutics AG
| Net Income | -366 M |
| Depreciation & Amortization | 19.3 M |
| Capital Expenditures | -1.9 M |
| Stock-Based Compensation | 86.6 M |
| Change in Working Capital | 156 M |
| Others | -57.3 M |
| Free Cash Flow | -145 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (366.3) | (153.6) | (650.2) | 377.7 | (348.9) | 66.9 | (165.0) | (68.4) | (23.2) | (25.8) | (6.8) |
| Depreciation & Amortization | 19.3 | 19.8 | 24.2 | 18.0 | 9.2 | 4.7 | 3.5 | 3.0 | 0.9 | 0.1 | 38 K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 4.3 | 0 | (53.7) | 20 K | 0 |
| Stock Based Compensation | 86.6 | 81.0 | 97.9 | 102.4 | 66.0 | 44.1 | 35.0 | 18.9 | 10.8 | 3.7 | 0.7 |
| Other Operating Activities | (38.6) | (14.0) | 12.5 | 14.1 | 1.9 | (10.5) | 15.4 | 1.8 | 8.1 | 97 K | (0.3) |
| Change in Working Capital | 156.3 | (193.6) | 19.8 | 26.9 | 33.4 | (48.4) | 10.6 | (25.4) | 1.8 | 81.4 | 1.5 |
| Cash From Operations | (142.8) | (260.4) | (495.7) | 539.0 | (238.4) | 56.7 | (96.2) | (70.1) | (55.3) | 59.4 | (4.8) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (1.9) | (12.0) | (37.2) | (81.7) | (18.4) | (6.7) | (2.8) | (7.8) | (3.0) | (1.2) | 0 |
| Other Items | (278.6) | 386.6 | (221.5) | (953.7) | (522.8) | 8.0 | 0 | (0.5) | 34.9 | 0 | 0 |
| Cash From Investing Activities | (280.5) | 374.6 | (258.7) | (1 035.4) | (541.2) | 1.3 | (2.8) | (8.3) | 31.9 | (1.2) | 0 |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 57 K | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35.0 | 38.2 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 31.3 | 29.9 | 37.6 | 37.7 | 33.9 | 16.0 | 8.9 | 2.6 | 59.1 | 58.5 | 5.1 |
| Cash From Financing Activities | 332.0 | 62.7 | 38.6 | 250.9 | 1 016.2 | 431.0 | 315.9 | 2.6 | 183.2 | 96.7 | 5.1 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (91.3) | 177.0 | (715.9) | (245.5) | 236.7 | 489.0 | 216.9 | (75.8) | 159.6 | 155.0 | 0.6 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (144.7) | (272.3) | (532.9) | 457.3 | (256.7) | 50.0 | (99.0) | (77.9) | (58.3) | 58.3 | (4.8) |